302 related articles for article (PubMed ID: 19040522)
21. Autoantibodies to human nuclear antigen(s)-HNA-in connective tissue diseases and other disorders.
Passaleva A; Vannucci F; Bonali A; Iannello GL; Massai G; Ricci M
Clin Exp Immunol; 1986 Jan; 63(1):17-25. PubMed ID: 3485482
[TBL] [Abstract][Full Text] [Related]
22. In vivo antinuclear antibodies of the skin: A rare phenomenon on direct immunofluorescence.
Chhabra S; Arora SK; Minz RW; Dogra S
Dermatol Online J; 2013 Apr; 19(4):15. PubMed ID: 24021374
[TBL] [Abstract][Full Text] [Related]
23. Association of Immunofluorescence pattern of Antinuclear Antibody with Specific Autoantibodies in the Bangladeshi Population.
Sharmin S; Ahmed S; Abu Saleh A; Rahman F; Choudhury MR; Hassan MM
Bangladesh Med Res Counc Bull; 2014 Aug; 40(2):74-8. PubMed ID: 26415344
[TBL] [Abstract][Full Text] [Related]
24. [Significance of speckled staining of epidermal nuclei in direct immunofluorescence. 10 cases (author's transl)].
Morel P; Peltier AP; Allegre P; Civatte J
Nouv Presse Med; 1978 Jul 1-8; 7(27):2377-80. PubMed ID: 353722
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathological significance of cutaneous epidermal nuclear staining by direct immunofluorescence.
Burrows NP; Bhogal BS; Russell Jones R; Black MM
J Cutan Pathol; 1993 Apr; 20(2):159-62. PubMed ID: 8320361
[TBL] [Abstract][Full Text] [Related]
26. The use of C3d and C4d immunohistochemistry on formalin-fixed tissue as a diagnostic adjunct in the assessment of inflammatory skin disease.
Magro CM; Dyrsen ME
J Am Acad Dermatol; 2008 Nov; 59(5):822-33. PubMed ID: 19119098
[TBL] [Abstract][Full Text] [Related]
27. Ineffectiveness of rat liver tissues in the screening of connective tissue disease.
Aziz KA
Saudi Med J; 2004 Apr; 25(4):442-6. PubMed ID: 15083212
[TBL] [Abstract][Full Text] [Related]
28. [Clinical evaluation of immuno-serological laboratory data].
Kasukawa R; Tojo J; Kuwana T; Obara K
Rinsho Byori; 1996 Dec; 44(12):1157-63. PubMed ID: 8990934
[TBL] [Abstract][Full Text] [Related]
29. Comparison of different test systems for simultaneous autoantibody detection in connective tissue diseases.
Eissfeller P; Sticherling M; Scholz D; Hennig K; Lüttich T; Motz M; Kromminga A
Ann N Y Acad Sci; 2005 Jun; 1050():327-39. PubMed ID: 16014549
[TBL] [Abstract][Full Text] [Related]
30. [Detection of antinuclear antibodies and their significance as disease markers].
Yoshida H; Imafuku Y; Morita EO; Nagai T; Kato Y; Motegi S
Rinsho Byori; 1994 May; 42(5):455-9. PubMed ID: 8022074
[TBL] [Abstract][Full Text] [Related]
31. Correlation between ANA determinations on tissue substrate, WiL-2 cell substrate, and precipitin antibody by double diffusion.
Deng JS; Bair LW; Medsger TA; Sontheimer RA
Diagn Clin Immunol; 1987; 5(3):151-7. PubMed ID: 3121208
[TBL] [Abstract][Full Text] [Related]
32. [Serological diagnosis of systemic connective tissue inflammation; a new immunofluorescence method for demonstrating antinuclear antibodies].
Scagliusi P; Laghezza D; Ferrari G; Fasiello V; De Lucia M
Minerva Med; 1981 Jan; 72(2):81-90. PubMed ID: 7007926
[TBL] [Abstract][Full Text] [Related]
33. Comparison of antinuclear antibody testing methods: immunofluorescence assay versus enzyme immunoassay.
Gniewek RA; Stites DP; McHugh TM; Hilton JF; Nakagawa M
Clin Diagn Lab Immunol; 1997 Mar; 4(2):185-8. PubMed ID: 9067653
[TBL] [Abstract][Full Text] [Related]
34. Increased titres of anti-nuclear antibodies do not predict the development of associated disease in the absence of initial suggestive signs and symptoms.
Dinser R; Braun A; Jendro MC; Engel A
Scand J Rheumatol; 2007; 36(6):448-51. PubMed ID: 18092266
[TBL] [Abstract][Full Text] [Related]
35. Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay.
Op De Beeck K; Vermeersch P; Verschueren P; Westhovens R; Mariën G; Blockmans D; Bossuyt X
Autoimmun Rev; 2011 Oct; 10(12):801-8. PubMed ID: 21741497
[TBL] [Abstract][Full Text] [Related]
36. [Comparison of indirect immunofluorescence and enzyme immunoassay methods for the determination of antinuclear antibodies].
Yilmaz O; Karaman M; Ergon MC; Bahar IH; Yuluğ N
Mikrobiyol Bul; 2004; 38(1-2):85-90. PubMed ID: 15293906
[TBL] [Abstract][Full Text] [Related]
37. Antinuclear antibodies and connective tissue disease features in fibromyalgia syndrome: a controlled study.
Yunus MB; Hussey FX; Aldag JC
J Rheumatol; 1993 Sep; 20(9):1557-60. PubMed ID: 8164214
[TBL] [Abstract][Full Text] [Related]
38. Methods of choice for diagnostic antinuclear antibody (ANA) screening: benefit of adding antigen-specific assays to immunofluorescence microscopy.
Dahle C; Skogh T; Aberg AK; Jalal A; Olcén P
J Autoimmun; 2004 May; 22(3):241-8. PubMed ID: 15041045
[TBL] [Abstract][Full Text] [Related]
39. [Epidermal nuclear fluorescence of normal skin in connective tissue diseases].
Wollina U; Koch HJ; Knopf B
Dermatol Monatsschr; 1984; 170(11):699-702. PubMed ID: 6394393
[No Abstract] [Full Text] [Related]
40. [Dysthyroidism and connective pathology].
Schachter I; Antignani PL
Minerva Cardioangiol; 2006 Dec; 54(6):811-4. PubMed ID: 17396337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
